Several studies have reported elevated serum and CSF IL-6 levels and a strong correlation between CSF IL-6 levels with clinical signs in patients with NMO (128), and IL-6 receptor blockade results in a decreased relapse rate (130). Here, IL6 is linked to neuromyelitis optica.